Table 1.
Characteristic at LT | Median (IQR) or n (%) (n=7,220) |
---|---|
Age | 59 (52–66) |
| |
Female | 2,428 (34%) |
Male | 4,792 (66%) |
| |
White | 5,332 (74%) |
Black | 550 (8%) |
Asian | 276 (4%) |
Hispanic/Latino | 985 (14%) |
Multi-racial/other | 77 (1%) |
| |
Status 1 at transplant | 81 (1%) |
| |
Body mass index (BMI) | 27.8 (24.6–32.0) |
| |
Hepatitis C | 2,574 (36%) |
Cholestatic liver disease | 526 (7%) |
Non-cholestatic liver disease | 2,288 (32%) |
Hepatocellular carcinoma | 1,228 (17%) |
Other liver disease | 604 (8%) |
| |
Lab MELD at transplant | 17 (13–24) |
| |
Albumin at transplant (g/dl) | 2.9 (2.5–3.4) |
| |
Diabetes | 2,057 (28%) |
| |
Dialysis | 316 (4%) |
| |
No ascites | 1,346 (19%) |
Slight ascites | 4,010 (56%) |
Moderate ascites | 1,864 (26%) |
| |
Portal vein thrombosis at transplant | 546 (8%) |
| |
History of TIPSS | 768 (11%) |
| |
In intensive care unit (ICU) at LT | 504 (7%) |
Hospitalized, not in ICU | 970 (13%) |
Not hospitalized | 5,746 (80%) |
| |
Renal risk index (RRI) | 1.60 (0.99–2.84) |
| |
Donor risk index (DRI) | 1.45 (1.22–1.75) |